BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei M, Shi S, Hua J, Xu J, Yu X; Chinese Study Group for Pancreatic Cancer (CSPAC). Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1). BMJ Open 2019;9:e033452. [PMID: 31818843 DOI: 10.1136/bmjopen-2019-033452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Shao Y, Feng J, Hu Z, Wu J, Zhang M, Shen Y, Zheng S. Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study. Ann Med Surg (Lond) 2021;62:490-4. [PMID: 33680449 DOI: 10.1016/j.amsu.2020.11.037] [Reference Citation Analysis]
2 Macfie R, Berger Y, Sarpel U, Hiotis S, Golas B, Labow D, Cohen N. Surgical Management of Pancreatic Cancer Liver Oligometastases. Crit Rev Oncol Hematol 2022;:103654. [PMID: 35301097 DOI: 10.1016/j.critrevonc.2022.103654] [Reference Citation Analysis]
3 Wang Z, Jin Y, Guo Y, Tan Z, Zhang X, Ye D, Yu Y, Peng S, Zheng L, Li J. Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid. Cancers (Basel) 2021;13:1179. [PMID: 33803322 DOI: 10.3390/cancers13051179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ding J, Ren J, Chen F, Yue Y, Ren C, Wang X, Ma Q, Wu Z, Wang Z. Prognostic Nomogram for pancreatic cancer with lung metastasis: a SEER database-based study. Journal of Pancreatology 2021;4:28-36. [DOI: 10.1097/jp9.0000000000000059] [Reference Citation Analysis]